KMGIF yields 6.95% · JNJ yields 2.13%● Live data
📍 KMGIF pulled ahead of the other in Year 1
Combined, KMGIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KMGIF + JNJ for your $10,000?
Kamigumi Co., Ltd. provides an integrated logistics services in Japan and internationally. The company offers harbor transportation services; warehousing storage and distribution processing services; and truck, air, and rail transportation services, as well as sea freight services. It also provides on-site factory services, including loading and unloading of ship-borne raw materials; transportation of materials to sites; and provision of secondary processing, product controls/shipping work, and environmental response work services. In addition, the company offers heavy cargo transportation services for transformer plants, industrial equipment, petrochemical plant equipment, and railcars. Further, it provides construction services for housing, warehouses, offices, and stores; offers breakdown and disposal services for large equipment and facilities, such as steel plant rolling mill production lines and large conveyor systems for sand and rock; designs and constructs steel structures; constructs and maintains amusement facilities; and provides machinery maintenance services. Additionally, the company engages in apartment rental; alcoholic beverage production; and restaurant businesses, as well as solar business. It also develops and leases commercial facilities, operates parking areas, and cultivates tomatoes. Kamigumi Co., Ltd. was founded in 1867 and is headquartered in Kobe, Japan.
Full KMGIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.